These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
87 related items for PubMed ID: 9713497
21. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation. Yang BF, Xiao C, Li H, Yang SJ. Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862 [Abstract] [Full Text] [Related]
23. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB. Kasof GM, Lu JJ, Liu D, Speer B, Mongan KN, Gomes BC, Lorenzi MV. Oncogene; 2001 Nov 29; 20(55):7965-75. PubMed ID: 11753679 [Abstract] [Full Text] [Related]
24. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells. Milner AE, Palmer DH, Hodgkin EA, Eliopoulos AG, Knox PG, Poole CJ, Kerr DJ, Young LS. Cell Death Differ; 2002 Mar 29; 9(3):287-300. PubMed ID: 11859411 [Abstract] [Full Text] [Related]
25. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation. Rödel F, Hantschel M, Hildebrandt G, Schultze-Mosgau S, Rödel C, Herrmann M, Sauer R, Voll RE. Int J Radiat Biol; 2004 Feb 29; 80(2):115-23. PubMed ID: 15164793 [Abstract] [Full Text] [Related]
26. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma. Kim R, Tanabe K, Inoue H, Toge T. Int J Oncol; 2002 Mar 29; 20(3):549-55. PubMed ID: 11836567 [Abstract] [Full Text] [Related]
28. CD95 apoptosis resistance in certain cells can be overcome by noncanonical activation of caspase-8. Barnhart BC, Pietras EM, Algeciras-Schimnich A, Salmena L, Sayama K, Hakem R, Peter ME. Cell Death Differ; 2005 Jan 29; 12(1):25-37. PubMed ID: 15499374 [Abstract] [Full Text] [Related]
29. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I. Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619 [Abstract] [Full Text] [Related]
30. Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB. Schmelz K, Wieder T, Tamm I, Müller A, Essmann F, Geilen CC, Schulze-Osthoff K, Dörken B, Daniel PT. Oncogene; 2004 Sep 02; 23(40):6743-59. PubMed ID: 15273737 [Abstract] [Full Text] [Related]
31. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Weldon CB, Parker AP, Patten D, Elliott S, Tang Y, Frigo DE, Dugan CM, Coakley EL, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Int J Oncol; 2004 Jun 02; 24(6):1473-80. PubMed ID: 15138590 [Abstract] [Full Text] [Related]
32. DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. Huang HL, Fang LW, Lu SP, Chou CK, Luh TY, Lai MZ. Oncogene; 2003 Nov 06; 22(50):8168-77. PubMed ID: 14603257 [Abstract] [Full Text] [Related]
33. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses. Konstantakou EG, Voutsinas GE, Karkoulis PK, Aravantinos G, Margaritis LH, Stravopodis DJ. Int J Oncol; 2009 Aug 06; 35(2):401-16. PubMed ID: 19578756 [Abstract] [Full Text] [Related]
34. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Chen X, Kandasamy K, Srivastava RK. Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723 [Abstract] [Full Text] [Related]
35. Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis. Belka C, Rudner J, Wesselborg S, Stepczynska A, Marini P, Lepple-Wienhues A, Faltin H, Bamberg M, Budach W, Schulze-Osthoff K. Oncogene; 2000 Feb 24; 19(9):1181-90. PubMed ID: 10713706 [Abstract] [Full Text] [Related]
36. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC. Oncogene; 2003 Jul 17; 22(29):4498-508. PubMed ID: 12881706 [Abstract] [Full Text] [Related]
37. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R, Bedi A. Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014 [Abstract] [Full Text] [Related]
38. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells. Toyozumi Y, Arima N, Izumaru S, Kato S, Morimatsu M, Nakashima T. Int J Oncol; 2004 Sep 01; 25(3):721-8. PubMed ID: 15289875 [Abstract] [Full Text] [Related]
39. Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Zheng PW, Chiang LC, Lin CC. Life Sci; 2005 Feb 04; 76(12):1367-79. PubMed ID: 15670616 [Abstract] [Full Text] [Related]
40. Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells. Kang YH, Lee KA, Ryu CJ, Lee HG, Lim JS, Park SN, Paik SG, Yoon DY. Cancer Lett; 2006 Jun 08; 237(1):33-44. PubMed ID: 16019139 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]